Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 30 citing articles:

Significance of flavonoids targeting PI3K/Akt/HIF-1α signaling pathway in therapy-resistant cancer cells – A potential contribution to the predictive, preventive, and personalized medicine
Alena Mazuráková, Lenka Koklesová, Sandra Hurta Csizmár, et al.
Journal of Advanced Research (2023) Vol. 55, pp. 103-118
Open Access | Times Cited: 30
Systemic Inflammation as the Health-Related Communication Tool Between the Human Host and Gut Microbiota in the Framework of Predictive, Preventive, and Personalized Medicine
Payam Behzadi, Verónica I. Dodero, Olga Golubnitschaja
Advances in predictive, preventive and personalised medicine (2024), pp. 203-241
Closed Access | Times Cited: 14
Reprogramming of glucose metabolism: The hallmark of malignant transformation and target for advanced diagnostics and treatments
Qing Tang, Siqi Wu, Baiming Zhao, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 178, pp. 117257-117257
Open Access | Times Cited: 10
Anti-cancer potential of hydroethanolic extracts of Kyllinga nemoralis: an in vitro and in-silico studies
Eunice E. Ampem Danso, Justice Kumi, Abigail Aning, et al.
Pharmacological Research - Natural Products (2025) Vol. 6, pp. 100161-100161
Closed Access | Times Cited: 1
Comparative efficacy of epigallocatechin gallate and its nano-formulation in prostate cancer 3D spheroids model
Read F. Alserihi, Mohammed Razeeth Shait Mohammed, Mohammed Kaleem, et al.
Journal of King Saud University - Science (2023) Vol. 35, Iss. 4, pp. 102627-102627
Open Access | Times Cited: 20
Phytochemical-based nanodrugs going beyond the state-of-the-art in cancer management—Targeting cancer stem cells in the framework of predictive, preventive, personalized medicine
Lenka Koklesová, Jana Jakubı́ková, Dana Cholujová, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 19
Artificial intelligence in ovarian cancer drug resistance advanced 3PM approach: subtype classification and prognostic modeling
Cong Zhang, Jinxiang Yang, Siyu Chen, et al.
The EPMA Journal (2024) Vol. 15, Iss. 3, pp. 525-544
Closed Access | Times Cited: 6
Targeting benign prostate hyperplasia treatments: AR/TGF-β/NOX4 inhibition by apocynin suppresses inflammation and proliferation
Bo‐Ram Jin, Hyo-Jung Kim, Jung‐Hyun Na, et al.
Journal of Advanced Research (2023) Vol. 57, pp. 135-147
Open Access | Times Cited: 13
CVD phenotyping in oncologic disorders: cardio-miRNAs as a potential target to improve individual outcomes in revers cardio-oncology
Ming Yang, Tiepeng Li, Shujin Guo, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 5
The Role of Different Types of microRNA in the Pathogenesis of Breast and Prostate Cancer
Ekaterina A. Sidorova, Yury V. Zhernov, Marina A. Antsupova, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 1980-1980
Open Access | Times Cited: 11
Flavonoids attenuate cancer metabolism by modulating Lipid metabolism, amino acids, ketone bodies and redox state mediated by Nrf2
Marek Samec, Alena Mazuráková, Vincent Lučanský, et al.
European Journal of Pharmacology (2023) Vol. 949, pp. 175655-175655
Closed Access | Times Cited: 11
Feasibility and acceptability of a personalised primary prevention strategy for women and men at high risk of breast and prostate cancer: the 3PC study protocol for a pilot randomised controlled trial
Intissar Souli, Julie Lapointe, Jura Kinsley-Marlie, et al.
BMJ Open (2025) Vol. 15, Iss. 2, pp. e085255-e085255
Open Access
Inflammation-related indicators have a potential to increase overall quality of the prostate cancer management: a narrative review
Minjie Zhou, Jingyi Liang, Jialiang Hui, et al.
Translational Andrology and Urology (2023) Vol. 12, Iss. 5, pp. 809-822
Open Access | Times Cited: 10
Traditional Chinese medicine as a protective strategy against chemotherapy-induced cardiotoxicity: An overview of the literature
Junwei Wang, Hong Shao, You-Ni Zhang, et al.
Journal of Traditional and Complementary Medicine (2024) Vol. 15, Iss. 2, pp. 107-118
Open Access | Times Cited: 3
Harnessing Phytochemicals to Modulate the Nonsense-mediated Decay Pathway for Anticancer Drug Discovery
Sanjoy Majumder, Rutupurna Das, G. Panigrahi
Research Journal of Pharmacy and Technology (2025), pp. 489-494
Closed Access
Therapy-resistant breast cancer in focus: Clinically relevant mitigation by flavonoids targeting cancer stem cells
Alena Mazuráková, Lenka Koklesová, Desanka Výbohová, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 8
Personalized Drug Treatment
Abhirup Khanna, Sapna Jain
(2024), pp. 295-319
Closed Access | Times Cited: 3
Improving Whole Tomato Transformation for Prostate Health: Benign Prostate Hypertrophy as an Exploratory Model
Pier Giorgio Natali, Mauro Piantelli, Marco Minacori, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5795-5795
Open Access | Times Cited: 7
Immune-related gene methylation prognostic instrument for stratification and targeted treatment of ovarian cancer patients toward advanced 3PM approach
Wenshuang Jia, Na Li, Jingjing Wang, et al.
The EPMA Journal (2024) Vol. 15, Iss. 2, pp. 375-404
Closed Access | Times Cited: 2
Rhodiola rosea: a review in the context of PPPM approach
Wenqian Xu, Tianchuang Yang, Jinyuan Zhang, et al.
The EPMA Journal (2024) Vol. 15, Iss. 2, pp. 233-259
Closed Access | Times Cited: 2
Inhibition of GluN2B pathway is involved in the neuroprotective effect of silibinin on streptozotocin-induced Alzheimer's disease models
Panwen Liu, Chenkang Wang, Wenhui Chen, et al.
Phytomedicine (2022) Vol. 109, pp. 154594-154594
Closed Access | Times Cited: 10
IQGAP3 is relevant to prostate cancer: A detailed presentation of potential pathomechanisms
Wenjuan Mei, Ying Dong, Yan Gu, et al.
Journal of Advanced Research (2023) Vol. 54, pp. 195-210
Open Access | Times Cited: 6
Advances in Molecular Regulation of Prostate Cancer Cells by Top Natural Products of Malaysia
José M. Prieto, Mohd Mukrish Mohd Hanafi
Current Issues in Molecular Biology (2023) Vol. 45, Iss. 2, pp. 1536-1567
Open Access | Times Cited: 6
Global burden of cancers attributable to tobacco smoking, 1990–2019: an ecological study
Rajesh Sharma, Bijoy Rakshit
The EPMA Journal (2022) Vol. 14, Iss. 1, pp. 167-182
Open Access | Times Cited: 9
Potential Treatment Options for Neuroblastoma with Polyphenols through Anti-Proliferative and Apoptotic Mechanisms
Aisha Kafoud, Zoya Salahuddin, Raghad Sabaawi Ibrahim, et al.
Biomolecules (2023) Vol. 13, Iss. 3, pp. 563-563
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top